News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Durgam Suresh K.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/13/2023 |
4
| Durgam Suresh K. (EVP, Chief Medical Officer) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns:
| Sold 6,998 shares
@ $45.08, valued at
$315.5k
Sold 346 shares
@ $44.29, valued at
$15.3k
Exercised 7,344 restricted stock units
@ $0 |
|
03/08/2023 |
4
| Durgam Suresh K. (EVP, Chief Medical Officer) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns:
| Granted 39,398 restricted stock units
@ $0 |
|
02/27/2023 |
4
| Durgam Suresh K. (SVP, Chief Medical Officer) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns:
| Sold 7,906 shares
@ $47.14, valued at
$372.7k
Exercised 7,906 restricted stock units
@ $0 |
|
02/22/2023 |
4
| Durgam Suresh K. (SVP, Chief Medical Officer) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns:
| Sold 6,673 shares
@ $46.55, valued at
$310.6k
Sold 800 shares
@ $47.2, valued at
$37.8k
Sold 806 shares
@ $48.63, valued at
$39.2k
Sold 75 shares
@ $49.6, valued at
$3.7k
Exercised 8,354 restricted stock units
@ $0 |
|
03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/20/2022 |
4
| Durgam Suresh K. (Chief Medical Officer) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns:
| Sold 6,223 shares
@ $42.03, valued at
$261.6k
|
|
01/11/2022 |
4
| Durgam Suresh K. (Chief Medical Officer) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns:
| Sold 1,520 shares
@ $41.48, valued at
$63k
Sold 4,850 shares
@ $40.63, valued at
$197.1k
Sold 500 shares
@ $39.83, valued at
$19.9k
Exercised 13,093 restricted stock units
@ $0 |
|
02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/28/2020 |
3
| Durgam Suresh K. (Chief Medical Officer) has filed a Form 3 on Intra-Cellular Therapies, Inc. |
|
|